Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -68.62% is in line with its 3-year average of -65.79%, around the middle of its 3-year range (-78.30%–-56.83%).
0.17% above its 12-month average of -68.74%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -71.11%.
OPERATING MARGIN
-68.62%
OPERATING MARGIN AVG TTM
-68.74%
OPERATING MARGIN AVG 3Y
-65.41%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.17%
CURRENT VS 3Y AVG
-4.91%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 494 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CeriBell, Inc.
Market Cap
$943.26M
Operating Margin
-68.62%
TTM Avg
-68.74%
3Y Avg
-65.41%
5Y Avg
N/A
Market Cap
$942.78M
Operating Margin
-449.94%
TTM Avg
-404.25%
3Y Avg
-202.12%
5Y Avg
-134.75%
Market Cap
$922.50M
Operating Margin
-192.08%
TTM Avg
-714.41%
3Y Avg
-506.77%
5Y Avg
-588.71%
Market Cap
$921.45M
Operating Margin
8.04%
TTM Avg
6.98%
3Y Avg
6.09%
5Y Avg
5.66%
Market Cap
$915.95M
Operating Margin
10.63%
TTM Avg
4.11%
3Y Avg
-10.10%
5Y Avg
-5.16%
Market Cap
$903.13M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$985.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-59.79%
Market Cap
$989.05M
Operating Margin
-1149.52%
TTM Avg
-2324.93%
3Y Avg
-1162.47%
5Y Avg
-1162.47%
Market Cap
$1.01B
Operating Margin
-1576.67%
TTM Avg
-1255.13%
3Y Avg
-1048.04%
5Y Avg
-849.59%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CeriBell, Inc. (CBLL) | $943.26M | -68.62% | -68.74% | -65.41% | N/A |
| Kura Oncology, Inc. (KURA)vs › | $942.78M | -449.94% | -404.25% | -202.12% | -134.75% |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | -192.08% | -714.41% | -506.77% | -588.71% |
| HealthStream, Inc. (HSTM)vs › | $921.45M | 8.04% | 6.98% | 6.09% | 5.66% |
| Bioventus Inc. (BVS)vs › | $915.95M | 10.63% | 4.11% | -10.10% | -5.16% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | 0.00% | 0.00% | 0.00% | -59.79% |
| Aktis Oncology, Inc. (AKTS)vs › | $989.05M | -1149.52% | -2324.93% | -1162.47% | -1162.47% |
| Janux Therapeutics, Inc. (JANX)vs › | $1.01B | -1576.67% | -1255.13% | -1048.04% | -849.59% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -43.83% | -75.55% | -37.77% | -25.18% |
Gross Margin
88.9%
Operating Margin
-68.6%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -71.11% |
| 2026-03-31 | -78.30% |
| 2025-12-31 | -58.89% |
| 2025-09-30 | -64.84% |
| 2025-06-30 | -70.53% |
| 2025-03-31 | -69.33% |
| 2024-12-31 | -69.52% |
| 2024-09-30 | -57.79% |
| 2024-06-30 | -56.83% |
| 2024-03-31 | -56.83% |
| 2023-12-31 | -63.83% |
| 2023-09-30 | -61.70% |
| 2023-06-30 | -70.77% |
| 2023-03-31 | -70.77% |
